vs
INVO Fertility, Inc.(IVF)与永明金融(TOP)财务数据对比。点击上方公司名可切换其他公司
永明金融的季度营收约是INVO Fertility, Inc.的1.6倍($2.9M vs $1.8M),永明金融净利率更高(6.6% vs -150.5%,领先157.2%)
INVO Fertility是一家专注于辅助生殖医疗解决方案的企业,核心产品为专利INVOcell阴道内培养装置,服务北美、欧洲等地区的生殖诊所与患者,致力于降低生育治疗门槛,为有需求的群体提供可负担的生殖医疗服务。
永明金融是一家总部位于加拿大安大略省多伦多的金融服务公司,创立于1865年,业务遍及全球,主营人寿保险、财富管理与资产管理。截至2024年,该公司管理资产规模超过1.3万亿加元,服务覆盖加拿大、美国、亚洲及多个其他市场。
IVF vs TOP — 直观对比
营收规模更大
TOP
是对方的1.6倍
$1.8M
净利率更高
TOP
高出157.2%
-150.5%
损益表 — Q3 FY2025 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $1.8M | $2.9M |
| 净利润 | $-2.6M | $190.5K |
| 毛利率 | — | — |
| 营业利润率 | -93.1% | — |
| 净利率 | -150.5% | 6.6% |
| 营收同比 | 22.6% | — |
| 净利润同比 | -62.2% | — |
| 每股收益(稀释后) | $-0.77 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
IVF
TOP
| Q3 25 | $1.8M | $2.9M | ||
| Q2 25 | $1.9M | — | ||
| Q1 25 | $1.6M | — | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $1.4M | — | ||
| Q2 24 | $1.8M | — | ||
| Q1 24 | $1.6M | — | ||
| Q4 23 | $1.4M | — |
净利润
IVF
TOP
| Q3 25 | $-2.6M | $190.5K | ||
| Q2 25 | $-5.3M | — | ||
| Q1 25 | $-17.4M | — | ||
| Q4 24 | $-3.6M | — | ||
| Q3 24 | $-1.6M | — | ||
| Q2 24 | $-2.2M | — | ||
| Q1 24 | $-1.6M | — | ||
| Q4 23 | $-2.0M | — |
毛利率
IVF
TOP
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 41.4% | — | ||
| Q3 24 | 31.0% | — | ||
| Q2 24 | 53.1% | — | ||
| Q1 24 | 45.3% | — | ||
| Q4 23 | 33.0% | — |
营业利润率
IVF
TOP
| Q3 25 | -93.1% | — | ||
| Q2 25 | -160.4% | — | ||
| Q1 25 | -1042.1% | — | ||
| Q4 24 | -202.0% | — | ||
| Q3 24 | -90.7% | — | ||
| Q2 24 | -100.9% | — | ||
| Q1 24 | -95.7% | — | ||
| Q4 23 | -109.2% | — |
净利率
IVF
TOP
| Q3 25 | -150.5% | 6.6% | ||
| Q2 25 | -283.6% | — | ||
| Q1 25 | -1060.1% | — | ||
| Q4 24 | -211.3% | — | ||
| Q3 24 | -113.8% | — | ||
| Q2 24 | -122.2% | — | ||
| Q1 24 | -101.3% | — | ||
| Q4 23 | -144.4% | — |
每股收益(稀释后)
IVF
TOP
| Q3 25 | $-0.77 | — | ||
| Q2 25 | $-13.30 | — | ||
| Q1 25 | $-12.53 | — | ||
| Q4 24 | $14.86 | — | ||
| Q3 24 | $-15.11 | — | ||
| Q2 24 | $-22.39 | — | ||
| Q1 24 | $-7.55 | — | ||
| Q4 23 | $-59.51 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $14.8M |
| 总债务越低越好 | $2.0M | — |
| 股东权益账面价值 | $5.8M | $35.0M |
| 总资产 | $18.8M | $64.1M |
| 负债/权益比越低杠杆越低 | 0.34× | — |
8季度趋势,按日历期对齐
现金及短期投资
IVF
TOP
| Q3 25 | — | $14.8M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
总债务
IVF
TOP
| Q3 25 | $2.0M | — | ||
| Q2 25 | $4.8M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $7.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
股东权益
IVF
TOP
| Q3 25 | $5.8M | $35.0M | ||
| Q2 25 | $2.6M | — | ||
| Q1 25 | $3.3M | — | ||
| Q4 24 | $12.7M | — | ||
| Q3 24 | $-23.3K | — | ||
| Q2 24 | $1.4M | — | ||
| Q1 24 | $10.2K | — | ||
| Q4 23 | $892.8K | — |
总资产
IVF
TOP
| Q3 25 | $18.8M | $64.1M | ||
| Q2 25 | $19.3M | — | ||
| Q1 25 | $31.7M | — | ||
| Q4 24 | $46.4M | — | ||
| Q3 24 | $17.0M | — | ||
| Q2 24 | $17.8M | — | ||
| Q1 24 | $17.3M | — | ||
| Q4 23 | $18.5M | — |
负债/权益比
IVF
TOP
| Q3 25 | 0.34× | — | ||
| Q2 25 | 1.83× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.59× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-1.8M | — |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | — |
| 自由现金流率自由现金流/营收 | -101.6% | — |
| 资本支出强度资本支出/营收 | 0.5% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-7.8M | — |
8季度趋势,按日历期对齐
经营现金流
IVF
TOP
| Q3 25 | $-1.8M | — | ||
| Q2 25 | $-1.7M | — | ||
| Q1 25 | $-3.5M | — | ||
| Q4 24 | $-617.4K | — | ||
| Q3 24 | $-640.8K | — | ||
| Q2 24 | $-1.5M | — | ||
| Q1 24 | $-260.6K | — | ||
| Q4 23 | $-714.9K | — |
自由现金流
IVF
TOP
| Q3 25 | $-1.8M | — | ||
| Q2 25 | $-1.7M | — | ||
| Q1 25 | $-3.6M | — | ||
| Q4 24 | $-696.3K | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-1.5M | — | ||
| Q1 24 | $-310.3K | — | ||
| Q4 23 | — | — |
自由现金流率
IVF
TOP
| Q3 25 | -101.6% | — | ||
| Q2 25 | -92.6% | — | ||
| Q1 25 | -216.9% | — | ||
| Q4 24 | -40.6% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -82.3% | — | ||
| Q1 24 | -19.7% | — | ||
| Q4 23 | — | — |
资本支出强度
IVF
TOP
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 4.6% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 3.0% | — | ||
| Q1 24 | 3.2% | — | ||
| Q4 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图